Literature DB >> 29697443

Injury Characteristics and von Willebrand Factor for the Prediction of Acute Respiratory Distress Syndrome in Patients With Burn Injury: Development and Internal Validation.

Majid Afshar1,2,3, Ellen L Burnham4,5, Cara Joyce3, Robin Gagnon1, Robert Dunn1, Joslyn M Albright6, Luis Ramirez1, John E Repine7, Giora Netzer8, Elizabeth J Kovacs4,9,10.   

Abstract

OBJECTIVE: To derive and validate a prediction model for the development of ARDS in burn-injured patients. SUMMARY BACKGROUND DATA: Burn injury carries the highest incidence of acute respiratory distress syndrome (ARDS) among all predisposing conditions, but few studies exist on risk factors in these patients. Studies employing biomarkers and clinical risk factors for predicting ARDS mortality have recently been examined but none exist for onset of ARDS nor in patients with burn injury.
METHODS: This was a prospective multicenter study of 113 patients with isolated burn injury or inhalation injury. Clinical variables and plasma biomarkers representative of endothelial injury, epithelial injury, or inflammation were collected within 24 hours of admission. The most parsimonious model was chosen by considering discrimination, calibration, and model fit.
RESULTS: Among the biomarkers measured in patients with burn injuries, a one-standard deviation increase in log-transformed levels of the A2 domain of von Willebrand factor in the first 24 hours was most strongly associated with the development of ARDS (OR 7.72; 95% CI: 1.64-36.28, P = 0.03). Of candidate models, a 3-variable model with %TBSA, inhalation injury, and von Willebrand factor-A2 had comparable discrimination to more complex models (area under the curve: 0.90; 95% CI 0.85-0.96). The 3-variable model had good model fit by Hosmer-Lemeshow test (P = 0.74) and maintained similar discrimination after accounting for performance optimism (Bootstrapped area under the curve: 0.90; 95% CI: 0.84-0.95).
CONCLUSIONS: The 3-variable model with %TBSA, inhalation injury, and von Willebrand factor could be used to better identify at-risk patients for both the study and prevention of ARDS in patients with burn injury.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29697443      PMCID: PMC6200654          DOI: 10.1097/SLA.0000000000002795

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

1.  Elevated pulmonary edema fluid concentrations of soluble intercellular adhesion molecule-1 in patients with acute lung injury: biological and clinical significance.

Authors:  E R Conner; L B Ware; G Modin; M A Matthay
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

2.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 4.  von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury.

Authors:  L B Ware; E R Conner; M A Matthay
Journal:  Crit Care Med       Date:  2001-12       Impact factor: 7.598

5.  Endothelial von Willebrand factor regulates angiogenesis.

Authors:  Richard D Starke; Francesco Ferraro; Koralia E Paschalaki; Nicola H Dryden; Thomas A J McKinnon; Rachel E Sutton; Elspeth M Payne; Dorian O Haskard; Alun D Hughes; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

6.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

Authors:  Michael A Matthay; Roy G Brower; Shannon Carson; Ivor S Douglas; Mark Eisner; Duncan Hite; Steven Holets; Richard H Kallet; Kathleen D Liu; Neil MacIntyre; Marc Moss; David Schoenfeld; Jay Steingrub; B Taylor Thompson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 7.  Clinical trials in acute respiratory distress syndrome: challenges and opportunities.

Authors:  Michael A Matthay; Daniel F McAuley; Lorraine B Ware
Journal:  Lancet Respir Med       Date:  2017-05-26       Impact factor: 30.700

8.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

Review 9.  Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Authors:  Carolyn S Calfee; Mark D Eisner; Polly E Parsons; B Taylor Thompson; Edward R Conner; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

Review 10.  Diabetes, insulin, and development of acute lung injury.

Authors:  Shyoko Honiden; Michelle N Gong
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

View more
  4 in total

1.  Inhalation Injury: Unmet Clinical Needs and Future Research.

Authors:  Kiran Dyamenahalli; Gaurav Garg; Jeffrey W Shupp; Paulius V Kuprys; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2019-08-14       Impact factor: 1.845

2.  NETosis in the pathogenesis of acute lung injury following cutaneous chemical burns.

Authors:  Ranu Surolia; Fu Jun Li; Zheng Wang; Mahendra Kashyap; Ritesh Kumar Srivastava; Amie M Traylor; Pooja Singh; Kevin G Dsouza; Harrison Kim; Jean-Francois Pittet; Jaroslaw W Zmijewski; Anupam Agarwal; Mohammad Athar; Aftab Ahmad; Veena B Antony
Journal:  JCI Insight       Date:  2021-05-24

Review 3.  Acute respiratory distress syndrome.

Authors:  Michael A Matthay; Rachel L Zemans; Guy A Zimmerman; Yaseen M Arabi; Jeremy R Beitler; Alain Mercat; Margaret Herridge; Adrienne G Randolph; Carolyn S Calfee
Journal:  Nat Rev Dis Primers       Date:  2019-03-14       Impact factor: 52.329

Review 4.  Endothelial Damage in Acute Respiratory Distress Syndrome.

Authors:  Alice G Vassiliou; Anastasia Kotanidou; Ioanna Dimopoulou; Stylianos E Orfanos
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.